Total Payments
$63,793
2024 Payments
$40,109
Companies
27
Transactions
177
Medicare Patients
2,204
Medicare Billing
$175,553
Payment Breakdown by Category
Other$34,060 (53.4%)
Travel$13,007 (20.4%)
Research$9,363 (14.7%)
Food & Beverage$5,679 (8.9%)
Consulting$1,620 (2.5%)
Education$64.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $34,060 | 12 | 53.4% |
| Travel and Lodging | $13,007 | 25 | 20.4% |
| Unspecified | $9,363 | 27 | 14.7% |
| Food and Beverage | $5,679 | 111 | 8.9% |
| Consulting Fee | $1,620 | 1 | 2.5% |
| Education | $64.00 | 1 | 0.1% |
Payments by Type
General
$54,430
150 transactions
Research
$9,363
27 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28,739 | 37 | $0 (2024) |
| Medtronic Vascular, Inc. | $10,696 | 17 | $0 (2020) |
| Medtronic, Inc. | $9,363 | 27 | $0 (2024) |
| Lilly USA, LLC | $8,332 | 9 | $0 (2024) |
| Abbott Laboratories | $5,084 | 36 | $0 (2023) |
| ABIOMED | $359.52 | 4 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $262.26 | 17 | $0 (2022) |
| ZOLL Respicardia, Inc. | $160.00 | 1 | $0 (2023) |
| CVRx, Inc. | $131.88 | 1 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $130.11 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40,109 | 57 | Boehringer Ingelheim Pharmaceuticals, Inc. ($28,353) |
| 2023 | $4,415 | 27 | Medtronic, Inc. ($3,063) |
| 2022 | $3,560 | 13 | Medtronic, Inc. ($2,975) |
| 2021 | $340.77 | 4 | Abbott Laboratories ($313.04) |
| 2020 | $375.05 | 7 | Abbott Laboratories ($130.75) |
| 2019 | $745.76 | 19 | ABIOMED ($234.53) |
| 2018 | $12,306 | 35 | Medtronic Vascular, Inc. ($10,280) |
| 2017 | $1,941 | 15 | Abbott Laboratories ($1,685) |
All Payment Transactions
177 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/12/2024 | Medtronic, Inc. | AURORA EV-ICD MRI SURESCAN (Device), MICRA, SELECTSECURE | — | Cash or cash equivalent | $262.50 | Research |
| Study: PSR-CVG • Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| Category: DIABETES | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $129.98 | General |
| Category: DIABETES | ||||||
| 11/02/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/14/2024 | Medtronic, Inc. | AURORA EV-ICD MRI SURESCAN (Device), MICRA, SELECTSECURE | — | Cash or cash equivalent | $262.50 | Research |
| Study: PSR-CVG • Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 10/11/2024 | Medtronic, Inc. | AURORA EV-ICD MRI SURESCAN (Device), MICRA, SELECTSECURE | — | Cash or cash equivalent | $175.00 | Research |
| Study: PSR-CVG • Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $80.64 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: DIABETES | ||||||
| 10/02/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Cardiology | ||||||
| 09/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: DIABETES | ||||||
| 09/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| Category: DIABETES | ||||||
| 08/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $50.88 | General |
| Category: DIABETES | ||||||
| 08/15/2024 | Medtronic, Inc. | AURORA EV-ICD MRI SURESCAN (Device), MICRA, SELECTSECURE | — | Cash or cash equivalent | $350.00 | Research |
| Study: PSR-CVG • Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 08/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: DIABETES | ||||||
| 07/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| Category: DIABETES | ||||||
| 07/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| Category: DIABETES | ||||||
| 07/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: DIABETES | ||||||
| 06/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $80.40 | General |
| Category: DIABETES | ||||||
| 06/19/2024 | Medtronic, Inc. | AURORA EV-ICD MRI SURESCAN (Device), MICRA, SELECTSECURE | — | Cash or cash equivalent | $262.50 | Research |
| Study: PSR-CVG • Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 06/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $97.89 | General |
| Category: DIABETES | ||||||
| 06/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,850.00 | General |
| Category: DIABETES | ||||||
| 06/13/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,080.00 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,570.00 | General |
| Category: Diabetes | ||||||
| 06/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $25.46 | General |
| Category: DIABETES | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PSR-CVG | Medtronic, Inc. | $9,363 | 27 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 755 | 849 | $171,995 | $52,295 |
| 2022 | 18 | 786 | 870 | $141,196 | $47,312 |
| 2021 | 10 | 371 | 552 | $123,186 | $46,787 |
| 2020 | 9 | 292 | 489 | $78,040 | $29,159 |
Total Patients
2,204
Total Services
2,760
Medicare Billing
$175,553
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 54 | 68 | $19,537 | $8,674 | 44.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 98 | $20,923 | $8,140 | 38.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 139 | 140 | $22,540 | $6,855 | 30.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 17 | 37 | $21,941 | $5,855 | 26.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 56 | 56 | $16,901 | $4,677 | 27.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 29 | 29 | $11,964 | $4,566 | 38.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 62 | 62 | $11,780 | $3,438 | 29.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 48 | $7,344 | $2,993 | 40.8% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 22 | 24 | $19,997 | $2,265 | 11.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,925 | $1,821 | 37.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 74 | 74 | $3,626 | $776.74 | 21.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 12 | 12 | $2,280 | $596.70 | 26.2% |
| G0250 | Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | Office | 2023 | 60 | 73 | $1,898 | $451.89 | 23.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 30 | 30 | $2,100 | $433.62 | 20.6% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 29 | 29 | $1,421 | $289.35 | 20.4% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 12 | 12 | $1,262 | $186.61 | 14.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 12 | 12 | $840.00 | $181.28 | 21.6% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 14 | 14 | $380.00 | $59.02 | 15.5% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 16 | 16 | $336.00 | $36.00 | 10.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 118 | 145 | $30,510 | $11,906 | 39.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 134 | 136 | $21,216 | $7,133 | 33.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $12,300 | $5,037 | 40.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 12 | 30 | $17,520 | $4,999 | 28.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 34 | $9,476 | $3,799 | 40.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 57 | 57 | $10,488 | $3,172 | 30.2% |
About Dr. Michael Dickinson, MD
Dr. Michael Dickinson, MD is a Cardiovascular Disease healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942289798.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Dickinson, MD has received a total of $63,793 in payments from pharmaceutical and medical device companies, with $40,109 received in 2024. These payments were reported across 177 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($34,060).
As a Medicare-enrolled provider, Dickinson has provided services to 2,204 Medicare beneficiaries, totaling 2,760 services with total Medicare billing of $175,553. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Advanced Heart Failure and Transplant Cardiology
- Location Grand Rapids, MI
- Active Since 01/11/2006
- Last Updated 06/25/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1942289798
Products in Payments
- JARDIANCE (Drug) $37,071
- HeartWare HVAD (Device) $10,076
- AURORA EV-ICD MRI SURESCAN (Device) $3,325
- Aurora (Device) $3,063
- MICRA (Device) $2,975
- HeartMate 3 Left Ventricular Dev (Device) $1,834
- Circulatory Support (Device) $1,817
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $778.11
- Impella (Device) $359.52
- HeartMate 3 Left Ventricular Assist Device (Device) $283.79
- ENTRESTO (Drug) $262.26
- CARDIOMEMS (Device) $211.63
- CardioMEMS HF System (Device) $160.00
- remede System (Device) $160.00
- Barostim Neo System (Device) $131.88
- UPTRAVI (Drug) $130.11
- VYNDAQEL (Drug) $43.50
- ELIQUIS (Drug) $41.42
- Veltassa (Drug) $32.98
- BRILINTA (Drug) $32.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Grand Rapids
Dr. Jihad Mustapha, M.d, M.D
Cardiovascular Disease — Payments: $2.1M
Cardiovascular Disease $2.1M
Dr. David Wohns, M.d, M.D
Cardiovascular Disease — Payments: $217,267
Cardiovascular Disease $217,267
Dr. David Fermin, M.d, M.D
Cardiovascular Disease — Payments: $66,123
Cardiovascular Disease $66,123
Dr. Andrew Lacombe, M.d, M.D
Cardiovascular Disease — Payments: $47,750
Cardiovascular Disease $47,750
Sangjin Lee, Md, Msc, MD, MSC
Cardiovascular Disease — Payments: $35,512
Cardiovascular Disease $35,512
Dr. Alfred Albano, M.d, M.D
Cardiovascular Disease — Payments: $28,586
Cardiovascular Disease $28,586